Status:
COMPLETED
PoCUS Guided Fluids to Prevent Post-induction Hypotension
Lead Sponsor:
Mount Sinai Hospital, Canada
Conditions:
Hypotension on Induction
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Hypotension is a common side-effect of general anesthesia induction, and is related to adverse outcomes, including a significantly increased risk of one-year mortality. Hypovolemia is a significant ri...
Detailed Description
Background: Hypotension is a common side-effect of general anesthesia induction, and is related to adverse outcomes, including significantly increasing risk of one-year mortality (intraoperative systo...
Eligibility Criteria
Inclusion
- Age 18-70 years
- Elective surgery
- IVC-CI ≥ 43% on their preoperative POCUS scan.
Exclusion
- Hypotension, defined as MAP below 65 mmhg, prior to the induction of general anesthesia.
- Treated with angiotensin converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB) on the day of surgery.
- Patients with heart failure with ejection fraction (EF) \< 40%.
- Patients with documented acute or chronic renal failure.
- Patients with neuraxial blockade (epidural or spinal) performed before induction of general anesthesia.
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05424510
Start Date
July 5 2022
End Date
February 22 2023
Last Update
March 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5